CYAN AG (CYR.DE) Fundamental Analysis & Valuation

FRA:CYR • DE000A2E4SV8

Current stock price

1.98 EUR
-0.04 (-1.98%)
Last:

This CYR.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CYR.DE Profitability Analysis

1.1 Basic Checks

  • In the past year CYR has reported negative net income.
  • In the past year CYR has reported a negative cash flow from operations.
  • In the past 5 years CYR always reported negative net income.
  • CYR had a negative operating cash flow in each of the past 5 years.
CYR.DE Yearly Net Income VS EBIT VS OCF VS FCFCYR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -6.26%, CYR is doing worse than 64.29% of the companies in the same industry.
  • CYR has a Return On Equity (-7.08%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROIC N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
CYR.DE Yearly ROA, ROE, ROICCYR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • CYR has a better Gross Margin (84.83%) than 79.46% of its industry peers.
  • In the last couple of years the Gross Margin of CYR has declined.
  • CYR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
CYR.DE Yearly Profit, Operating, Gross MarginsCYR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CYR.DE Health Analysis

2.1 Basic Checks

  • CYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CYR has less shares outstanding
  • CYR has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CYR has a worse debt to assets ratio.
CYR.DE Yearly Shares OutstandingCYR.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CYR.DE Yearly Total Debt VS Total AssetsCYR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 4.68 indicates that CYR is not in any danger for bankruptcy at the moment.
  • CYR has a better Altman-Z score (4.68) than 76.79% of its industry peers.
  • CYR has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • CYR has a better Debt to Equity ratio (0.05) than 77.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 4.68
ROIC/WACCN/A
WACC7.41%
CYR.DE Yearly LT Debt VS Equity VS FCFCYR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 2.24 indicates that CYR has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.24, CYR is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • A Quick Ratio of 2.24 indicates that CYR has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 2.24, CYR is doing good in the industry, outperforming 79.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
CYR.DE Yearly Current Assets VS Current LiabilitesCYR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CYR.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 86.12% over the past year.
  • Looking at the last year, CYR shows a very strong growth in Revenue. The Revenue has grown by 98.99%.
  • CYR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -23.31% yearly.
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%

3.2 Future

  • Based on estimates for the next years, CYR will show a very strong growth in Earnings Per Share. The EPS will grow by 35.44% on average per year.
  • The Revenue is expected to grow by 21.14% on average over the next years. This is a very strong growth
EPS Next Y76.67%
EPS Next 2Y42.59%
EPS Next 3Y33.89%
EPS Next 5Y35.44%
Revenue Next Year28.88%
Revenue Next 2Y25.88%
Revenue Next 3Y23.58%
Revenue Next 5Y21.14%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYR.DE Yearly Revenue VS EstimatesCYR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M
CYR.DE Yearly EPS VS EstimatesCYR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. CYR.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • CYR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 392.08, CYR can be considered very expensive at the moment.
  • 63.39% of the companies in the same industry are cheaper than CYR, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.12, CYR is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 392.08
CYR.DE Price Earnings VS Forward Price EarningsCYR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CYR indicates a slightly more expensive valuation: CYR is more expensive than 62.50% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 111.17
CYR.DE Per share dataCYR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as CYR's earnings are expected to grow with 33.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.59%
EPS Next 3Y33.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CYR.DE Dividend Analysis

5.1 Amount

  • CYR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CYR.DE Fundamentals: All Metrics, Ratios and Statistics

CYAN AG

FRA:CYR (4/27/2026, 7:00:00 PM)

1.98

-0.04 (-1.98%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)05-13
Inst Owners1.62%
Inst Owner ChangeN/A
Ins Owners35.76%
Ins Owner ChangeN/A
Market Cap42.93M
Revenue(TTM)8.28M
Net Income(TTM)-1.96M
Analysts83.33
Price Target4.44 (124.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 392.08
P/S 5.18
P/FCF N/A
P/OCF N/A
P/B 1.55
P/tB 19.49
EV/EBITDA 111.17
EPS(TTM)-0.1
EYN/A
EPS(NY)0.01
Fwd EY0.26%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.38
BVpS1.28
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.83%
FCFM N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 3.19
Cap/Depr 1.57%
Cap/Sales 0.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 4.68
F-Score5
WACC7.41%
ROIC/WACCN/A
Cap/Depr(3y)16.18%
Cap/Depr(5y)14.33%
Cap/Sales(3y)12.45%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y76.67%
EPS Next 2Y42.59%
EPS Next 3Y33.89%
EPS Next 5Y35.44%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%
Revenue Next Year28.88%
Revenue Next 2Y25.88%
Revenue Next 3Y23.58%
Revenue Next 5Y21.14%
EBIT growth 1Y-16.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.1%
EBIT Next 3Y39.05%
EBIT Next 5Y31.39%
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.64%
OCF growth 3YN/A
OCF growth 5YN/A

CYAN AG / CYR.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CYAN AG (CYR.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CYR.DE.


What is the valuation status for CYR stock?

ChartMill assigns a valuation rating of 1 / 10 to CYAN AG (CYR.DE). This can be considered as Overvalued.


How profitable is CYAN AG (CYR.DE) stock?

CYAN AG (CYR.DE) has a profitability rating of 1 / 10.


What is the expected EPS growth for CYAN AG (CYR.DE) stock?

The Earnings per Share (EPS) of CYAN AG (CYR.DE) is expected to grow by 76.67% in the next year.